Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man

S Lillioja, A A Young, C L Culter, J L Ivy, W G Abbott, J K Zawadzki, H Yki-Järvinen, L Christin, T W Secomb, C Bogardus, S Lillioja, A A Young, C L Culter, J L Ivy, W G Abbott, J K Zawadzki, H Yki-Järvinen, L Christin, T W Secomb, C Bogardus

Abstract

We have compared the capillary density and muscle fiber type of musculus vastus lateralis with in vivo insulin action determined by the euglycemic clamp (M value) in 23 Caucasians and 41 Pima Indian nondiabetic men. M value was significantly correlated with capillary density (r = 0.63; P less than or equal to 0.0001), percent type I fibers (r = 0.29; P less than 0.02), and percent type 2B fibers (r = -0.38; P less than 0.003). Fasting plasma glucose and insulin concentrations were significantly negatively correlated with capillary density (r = -0.46, P less than or equal to 0.0001; r = -0.47, P less than or equal to 0.0001, respectively). Waist circumference/thigh circumference ratio was correlated with percent type 1 fibers (r = -0.39; P less than 0.002). These results suggest that diffusion distance from capillary to muscle cells or some associated biochemical change, and fiber type, could play a role in determining in vivo insulin action. The association of muscle fiber type with body fat distribution may indicate that central obesity is only one aspect of a more generalized metabolic syndrome. The data may provide at least a partial explanation for the insulin resistance associated with obesity and for the altered kinetics of insulin action in the obese.

References

    1. J Clin Invest. 1986 Aug;78(2):472-81
    1. J Appl Physiol (1985). 1986 Jun;60(6):1923-31
    1. J Physiol. 1919 May 20;52(6):409-15
    1. J Clin Invest. 1986 Mar;77(3):908-15
    1. Acta Physiol Scand. 1977 Aug;100(4):385-92
    1. J Histochem Cytochem. 1955 May;3(3):170-95
    1. Histochem J. 1975 May;7(3):259-66
    1. Am J Physiol. 1971 Dec;221(6):1672-80
    1. J Biol Chem. 1978 Nov 25;253(22):8269-77
    1. J Clin Invest. 1960 Jul;39:1157-75
    1. J Clin Endocrinol Metab. 1983 Mar;56(3):608-11
    1. Diabetes. 1982 Apr;31(4 Pt 1):333-8
    1. Am J Physiol. 1986 Oct;251(4 Pt 1):E422-30
    1. Int J Obes. 1983;7(2):99-107
    1. Diabetes. 1981 Dec;30(12):1000-7
    1. Proc R Soc Lond B Biol Sci. 1983 Jan 22;217(1207):191-213
    1. Biochemistry. 1972 Jul 4;11(14):2627-33
    1. J Neurol Sci. 1973 Jan;18(1):111-29
    1. J Physiol. 1979 Sep;294:419-32
    1. J Clin Invest. 1984 Oct;74(4):1515-25
    1. Am J Physiol. 1983 Aug;245(2):E155-9
    1. Am J Physiol. 1985 Mar;248(3 Pt 1):E286-91
    1. J Neurol Sci. 1984 Jan;63(1):85-100
    1. Diabetes. 1973 Jun;22(6):442-58
    1. Diabetes. 1981 Jan;30(1):19-25
    1. Acta Med Scand. 1982;212(3):99-106
    1. Am J Clin Pathol. 1970 Aug;54(2):251-3
    1. Diabetes. 1984 Feb;33(2):153-9
    1. Ann N Y Acad Sci. 1959 Sep 25;82:420-30
    1. J Clin Endocrinol Metab. 1986 May;62(5):922-7
    1. Am J Physiol. 1985 May;248(5 Pt 1):E567-74
    1. Scand J Rehabil Med. 1983;15(2):55-61
    1. Diabetes. 1983 Jul;32(7):675-9
    1. J Clin Invest. 1984 Mar;73(3):800-5
    1. Diabetologia. 1969 Dec;5(6):416-9
    1. Diabetes. 1968 Nov;17(11):668-72
    1. N Engl J Med. 1986 Jan 23;314(4):193-8
    1. Acta Physiol Scand. 1975 Oct;95(2):203-5
    1. J Clin Endocrinol Metab. 1965 Oct;25(10):1375-84
    1. Microvasc Res. 1984 Jul;28(1):95-112
    1. Am J Physiol. 1979 Sep;237(3):E214-23
    1. J Physiol. 1977 Sep;270(3):677-90
    1. Diabetes Care. 1982 May-Jun;5(3):158-61
    1. J Clin Endocrinol Metab. 1986 Jun;62(6):1081-8
    1. Physiol Rev. 1953 Jul;33(3):245-325
    1. Diabetes. 1986 Mar;35(3):370-3
    1. J Clin Invest. 1984 Oct;74(4):1238-46
    1. J Appl Physiol Respir Environ Exerc Physiol. 1984 Jan;56(1):35-8
    1. Am J Physiol. 1984 Jun;246(6 Pt 1):E476-82
    1. Diabetologia. 1985 Mar;28(3):119-21

Source: PubMed

3
Subscribe